Position in ABSI
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,623,546
-$18,101 QoQ
Shares Held
541,182
+15.1% QoQ
Ownership
0.347%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds $54,956,129 across 12 Biotechnology names. ABSI ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
400,877 | $19,069,718 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
488,417 | $11,638,977 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
724,286 | $9,285,346 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
2,557,403 | $7,851,227 | |
| 5 | ABSI |
Absci Corp
This page
|
541,182 | $1,623,546 | |
| 6 | NRIX |
Nurix Therapeutics, Inc.
|
81,760 | $1,267,280 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
14,389 | $1,080,470 | |
| 8 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
114,255 | $882,048 |
All Filings in ABSI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,623,546 | 541,182 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,641,647 | 470,386 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $936,502 | 308,060 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $406,825 | 158,298 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $221,894 | 88,404 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $80,520 | 30,733 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $53,392 | 13,977 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||